Edgewell Personal Care Company (EPC) — Fair Value Analysis
Base-case fair value (P50): $24.95 · Current price: $28.42 · Verdict: Fairly Valued
The Verdict on EPC
EDGEWELL PERSONAL CARE (EPC) is currently assessed as Fairly Valued, according to our Monte Carlo simulations, despite its underlying weak quality tier. These extensive simulations, which model thousands of forward scenarios based on diverse market conditions and company performance, indicate a median fair value (P50) of $24.95 for EPC. This translates to an -12.2% difference when compared against the current market price of $28.42. While this gap suggests the stock is trading slightly above our median estimated fair value, the overall probabilistic assessment positions EPC as within a reasonable valuation range, aligning with the "Fairly Valued" verdict from our models.
How EPC stacks up against peers
The weak quality tier assigned to EDGEWELL PERSONAL CARE (EPC) highlights potential operational or financial health challenges when benchmarked against its broader sector. Despite these inherent challenges, our Monte Carlo analysis suggests that EPC's current price of $28.42 is largely consistent with its median fair value of $24.95. This implies that the market may have already largely discounted some of the concerns associated with its weak quality. The -12.2% figure further reinforces that, even with a weak fundamental backdrop, the valuation isn't substantially out of line with probabilistic future outcomes, reflecting a nuanced market perception.
What this means for investors
Investors considering EDGEWELL PERSONAL CARE (EPC) should take note of the Fairly Valued verdict derived from our robust Monte Carlo simulations. With a median fair value of $24.95 relative to the current market price of $28.42, and an -12.2% gap, immediate mispricing opportunities appear limited based on our P50 estimate. The combination of this valuation with a weak quality tier suggests a balanced risk-reward profile at the current $28.42. While our models account for various potential outcomes, our FairCurve analysis indicates that EPC is largely priced efficiently. To gain a comprehensive understanding of the full probabilistic distribution, including detailed bear-case and bull-case scenarios, sign up for FairCurve to track EPC's fair value as new fundamentals are released.
Frequently Asked Questions
Is EPC overvalued or undervalued right now?
Based on our Monte Carlo simulations, EDGEWELL PERSONAL CARE (EPC) is assessed as Fairly Valued, with a median fair value (P50) of $24.95 compared to its current price of $28.42.
What is the bear case and bull case for EPC?
Our Monte Carlo simulations generate a full probabilistic distribution for EPC, including distinct bear (P10) and bull (P90) case price targets. The complete range, along with the probability of upside, is available exclusively to FairCurve account holders.
How does FairCurve calculate EPC's fair value?
FairCurve employs Monte Carlo simulations to calculate EPC's fair value by modeling thousands of forward-looking scenarios, analyzing potential cash flows and market conditions to derive a probabilistic valuation range.
How can I track EPC's fair value as it changes?
You can add EPC to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuations whenever new earnings or significant fundamental data are released.